Thor Equities Group has unveiled plans to build a new 150,000-square-foot industrial building in Bergen County, eyeing further expansion of its platform in northern New Jersey.
Thor Equities Group has added more than 130,000 square feet of industrial space in New Jersey with its acquisition of a two-building complex in Newark.
A company that develops meat from cultured animal cells has become the second tenant to lease space at a newly repurposed, lab-ready building in Jersey City.
After decades of consolidation by Big Pharma, demand for modern lab and diagnostic space in New Jersey is on the rise, fueling rent growth and pushing some developers to consider new laboratory projects.
Thor Equities Group has landed a major tenant at its newly acquired life sciences campus in Bridgewater, inking a 101,500-square-foot lease with a biopharmaceutical company.
Thor Equities Group is eyeing plans to reposition a historic building in Jersey City into research and laboratory space, following its recent acquisition of the nearly 340,000-square-foot property.